Richardpruen (talk | contribs) (→Suggestions to add to this page: Added ethics study from K. E. Lund) |
|||
| Line 747: | Line 747: | ||
===[https://www.nih.gov/nih-style-guide/person-first-destigmatizing-language NIH Style Guide]=== | ===[https://www.nih.gov/nih-style-guide/person-first-destigmatizing-language NIH Style Guide]=== | ||
=== 2024: [https://www.biomedcentral.com/epdf/10.1186/s12954-024-00951-w?sharing_token=iksdbJmNbsU0FCuLKTmOqW_BpE1tBhCbnbw3BuzI2RPfoghhpaw1aXYiTmPkOUEsYD7zfW3Oxi8XXRKS3L0aH_O8eh3cyggC1VGtf5w_6JyeTOXweo5IMQG1Q6z_QN5P8n2nBrlzQiNW05fih5qb9c8XPyeef-ba33MTIQ9eqe4%3D Challenges in legitimizing further measures against smoking in jurisdictions with robust infrastructure for tobacco control: how far can the authorities allow themselves to go?] === | |||
* Central to our discussion is the research literature concerned with the concept of state-paternalism in tobacco control—the line between an ethically justified interference with the freedom of those who smoke and an exaggerated infringement disproportionate to the same people’s right to live as they choose. | |||
* In countries with an already advanced infrastructure for tobacco control, this dilemma might become quite intrusive for regulators. We ask that if people, who smoke are aware of and have accepted the risks, are willing to pay the price, smoke exclusively in designated areas, and make decisions uninfluenced by persuasive messages from manufacturers—is a further tightening of anti-smoking measures still legitimate? | |||
** Conclusion: We recommend that a further intensification of smoking control in countries that already have a welldeveloped policy in this area requires that regulators start to exploit the opportunity that lies in the ongoing diversification of the recreational nicotine market. | |||
* Karl Erik Lund and Gunnar Saebo; Harm Reduction Journal (2024) 21:33https://doi.org/10.1186/s12954-024-00951-w | |||
* Funding: Norwegian Institute of Public Health (Governmental) | |||
===2021: [https://derma.jmir.org/2021/1/e28415 The Use of Person-Centered Language in Medical Research Journals Focusing on Psoriasis: Cross-sectional Analysis]=== | ===2021: [https://derma.jmir.org/2021/1/e28415 The Use of Person-Centered Language in Medical Research Journals Focusing on Psoriasis: Cross-sectional Analysis]=== | ||
edits